Gene · 8317
Papers1,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,550
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Programmed cell death 11 modulates but not entirely relies on p53-HDM2 loop to facilitate G2/M transition in colorectal cancer cells. | Oncogenesis | 2023 | 38062028 | PubTator, text mining | PubMed |
| An integrative evaluation of circadian gene TIMELESS as a pan-cancer immunological and predictive biomarker. | Eur J Med Res | 2023 | 38053143 | PubTator, text mining | PubMed |
| Whole exome sequencing of patients with varicella-zoster virus and herpes simplex virus induced acute retinal necrosis reveals rare disease-associated genetic variants. | Front Mol Neurosci | 2023 | 38025266 | PubTator, text mining | PubMed |
| Fanconi anemia pathway regulation by FANCI in prostate cancer. | Front Oncol | 2023 | 38023254 | PubTator, text mining | PubMed |
| CDC7 inhibition induces replication stress-mediated aneuploid cells with an inflammatory phenotype sensitizing tumors to immune checkpoint blockade. | Nat Commun | 2023 | 37980406 | PubTator, text mining | PubMed |
| Inactivation of the tumor suppressor gene Apc synergizes with H. pylori to induce DNA damage in murine gastric stem and progenitor cells. | Sci Adv | 2023 | 37967175 | PubTator, text mining | PubMed |
| The nucleolar protein GNL3 prevents resection of stalled replication forks. | EMBO Rep | 2023 | 37965896 | PubTator, text mining | PubMed |
| A CRISPR-drug perturbational map for identifying compounds to combine with commonly used chemotherapeutics. | Nat Commun | 2023 | 37957169 | PubTator, text mining | PubMed |
| Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma. | J Immunother Cancer | 2023 | 37935564 | PubTator, text mining | PubMed |
| Protein kinase Cdc7 supports viral replication by phosphorylating Avibirnavirus VP3 protein. | J Virol | 2023 | 37902398 | PubTator, text mining | PubMed |
| Frontotemporal-TDP and LATE Neurocognitive Disorders: A Pathophysiological and Genetic Approach. | Brain Sci | 2023 | 37891841 | PubTator, text mining | PubMed |
| miR-28-based combination therapy impairs aggressive B cell lymphoma growth by rewiring DNA replication. | Cell Death Dis | 2023 | 37852959 | PubTator, text mining | PubMed |
| ADAR1 links R-loop homeostasis to ATR activation in replication stress response. | Nucleic Acids Res | 2023 | 37831098 | PubTator, text mining | PubMed |
| Novel miRNA-based drug CD5-2 reduces liver tumor growth in diethylnitrosamine-treated mice by normalizing tumor vasculature and altering immune infiltrate. | Front Immunol | 2023 | 37795103 | PubTator, text mining | PubMed |
| Therapeutic targeting of the TPX2/TTK network in colorectal cancer. | Cell Commun Signal | 2023 | 37770979 | PubTator, text mining | PubMed |
| CDC7 kinase inhibitors: a survey of recent patent literature (2017-2022). | Expert Opin Ther Pat | 2023 | 37735909 | PubTator, text mining | PubMed |
| Network pharmacology combined with molecular docking and in vitro verification reveals the therapeutic potential of Delphinium roylei munz constituents on breast carcinoma. | Front Pharmacol | 2023 | 37724182 | PubTator, text mining | PubMed |
| Regulation of phosphoglycerate kinase 1 and its critical role in cancer. | Cell Commun Signal | 2023 | 37723547 | PubTator, text mining | PubMed |
| Ginsenoside Rk1 inhibits HeLa cell proliferation through an endoplasmic reticulum signaling pathway. | J Ginseng Res | 2023 | 37720575 | PubTator, text mining | PubMed |
| Identification of the H3K36me3 reader LEDGF/p75 in the pancancer landscape and functional exploration in clear cell renal cell carcinoma. | Comput Struct Biotechnol J | 2023 | 37675289 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8317/papers?page=5